1. A novel inflammation‑associated prognostic signature for clear cell renal cell carcinoma
   Gangcheng Liu et al, 2022, Oncology Letters CrossRef
2. Features of the microenvironment of oncourological tumors
   Oleg E. Molchanov et al, 2023, Urology reports (St. - Petersburg) CrossRef
3. A hint for the obesity paradox and the link between obesity, perirenal adipose tissue and Renal Cell Carcinoma progression
   José Preza-Fernandes et al, 2022, Scientific Reports CrossRef
4. High Immunoexpression of COX-2 as a Metastatic Risk Factor in ccRCC without PD-L1 Involvement
   Sri Suryanti et al, 2021, Research and Reports in Urology CrossRef
5. A Network Pharmacology and Molecular-Docking-Based Approach to Identify the Probable Targets of Short-Chain Fatty-Acid-Producing Microbial Metabolites against Kidney Cancer and Inflammation
   Md. Rezaul Karim et al, 2023, Biomolecules CrossRef
6. Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator
   Dipanjan Karati et al, 2024, Medical Oncology CrossRef
7. Prognostic Value of the Lung Immune Prognostic Index on Recurrence after Radical Surgery for High-Risk Renal Cell Carcinoma
   Yudai Ishiyama et al, 2024, Cancers CrossRef
8. Novel Expression of Thymine Dimers in Renal Cell Carcinoma, Demonstrated through Immunohistochemistry
   Dorin Novacescu et al, 2022, Biomedicines CrossRef
9. Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma
   Benjamin N. Schmeusser et al, 2023, Current Urology Reports CrossRef
10. Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
    Lin Hou et al, 2023, Genetics Research CrossRef
11. Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms’ Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49)
    Dorin Novacescu et al, 2022, Biomedicines CrossRef
12. Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
    Andreea Parosanu et al, 2022, Cureus CrossRef
13. Inflammation in Urological Malignancies: The Silent Killer
    Martina Catalano et al, 2023, International Journal of Molecular Sciences CrossRef
14. Pre-treatment systemic immune-inflammation index as a non-invasive biomarker for predicting clinical outcomes in patients with renal cell carcinoma: a meta-analysis of 20 studies
    Jun Xu et al, 2023, Biomarkers CrossRef
15. Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma
    Nikolas Dovrolis et al, 2023, Cancers CrossRef
16. Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy
    Xinglin Chen et al, 2023, Genetics Research CrossRef
17. Therapeutic Effects of Perilla Phenols in Oral Squamous Cell Carcinoma
    Chia-Huei Lee et al, 2023, International Journal of Molecular Sciences CrossRef